Vanderbilt Institute for Clinical and Translational Research Archive

VUMC’s new automated biobanking system can store as many as 10 million biospecimens.

August 25, 2022

New high-tech biobank safeguards critical specimens

April 6, 2022

Major grant renewal to provide five more years of support for VICTR

Vanderbilt University Medical Center has competed successfully for a third renewal of its Clinical and Translational Science Award by the National Institutes of Health.

By Bill Snyder

November 11, 2021

Translational Research Forum honors scientific excellence

Vanderbilt University Medical Center’s strength in translational research, which helps “translate” scientific discovery into medical practice, was celebrated recently during the Vanderbilt Translational Research Forum

By Bill Snyder

April 19, 2021

VUMC aids national effort to repurpose drugs for COVID-19

Vanderbilt University Medical Center (VUMC) has been named Data Coordinating Center (DCC) for a nationwide platform of studies aimed at “repurposing” existing drugs to treat mild to moderate symptoms of COVID-19.

By Bill Snyder

April 1, 2021

Study outlines VUMC’s strategy for a learning health care system

New investments in clinical programs at Vanderbilt University Medical Center are increasingly contingent upon studies to validate claims of benefit and the potential for scalability and spread.

By Paul Govern

The study team includes (seated, from left) Adrienne Baughman, CCRP; Bob McClellan; Wesley Self, MD, MPH; Christina Kampe, CCRP; (standing, from left) Rendie McHenry; Bo Stubblefield, MD; Jon Casey, MD, MSCI; Todd Rice, MD, MSc; Natasha Halasa, MD, MPH; Jakea Johnson, MPH; Jim Chappell, MD, PhD; Carlos Grijalva, MD, MPH; and Kelsey Womack, PhD. Not pictured are Julia Rhoads, PhD; Chris Lindsell, PhD; Keipp Talbot; MD, MPH; and Kimberly Hart, MA. (photo by Donn Jones)

March 2, 2021

Study to evaluate effectiveness of COVID-19 vaccines in preventing hospitalization

As the Federal Drug Administration (FDA) considers adding a third COVID-19 vaccine to the rollout, a multicenter study led by Vanderbilt University Medical Center will evaluate how effective the vaccines are in preventing hospitalization from COVID-19.

By Kristin Smart

July 23, 2020 Rice named to new leadership role for VICTR operations
Todd Rice, MD, MSc, has been appointed vice president for Clinical Trial Innovation and Operations in the Vanderbilt Institute for Clinical and Translational Research (VICTR).
By Bill Snyder
April 23, 2020 VUMC team creates COVID-19 research registry
Out of the electronic health records (EHRs) of patients seen at Vanderbilt University Medical Center, a team in the Department of Biomedical Informatics is creating a COVID-19 patient registry as a platform for research.
By Paul Govern
December 12, 2019 A new anti-seizure target?
Vanderbilt neurologists have identified a protein modification that could be targeted to reduce neuronal excitability in epilepsy.
By Leigh MacMillan
October 3, 2019 Study: personalized decision support affects intensive care
For patients in pediatric intensive care who are at high risk for acute kidney injury (AKI), giving clinicians automated decision support during the electronic order entry process increased the rate of blood testing for AKI by 9%.
By Paul Govern
October 2, 2019 Research team sorts out drug screen false positive results
Vanderbilt investigators have identified 13 previously unknown drug compounds that cause false positive screenings for amphetamines, buprenorphine (an opioid), cannabinoids and methadone.
By Paul Govern
July 11, 2019 Working memory in psychotic disorders
Functional MRI studies have revealed that targeting activation of certain brain regions may improve working memory and cognition in psychotic disorders.
By Kelsey Herbers
July 8, 2019 Clinical study tests drug that may prevent cancer metastasis
A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.
By Leigh MacMillan